Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 110.2 SEK 0.64% Market Closed
Market Cap: 11.1B SEK
Have any thoughts about
Biogaia AB?
Write Note

Biogaia AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biogaia AB
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Biogaia AB
STO:BIOG B
Operating Income
kr441.3m
CAGR 3-Years
25%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Operating Income
kr94.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Operating Income
-kr3.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probi AB
STO:PROB
Operating Income
kr4.1m
CAGR 3-Years
-68%
CAGR 5-Years
-49%
CAGR 10-Years
-14%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Operating Income
kr5.9B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
BioArctic AB
STO:BIOA B
Operating Income
kr264.6m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
N/A
No Stocks Found

Biogaia AB
Glance View

Market Cap
11.1B SEK
Industry
Biotechnology

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

BIOG B Intrinsic Value
113.42 SEK
Undervaluation 3%
Intrinsic Value
Price

See Also

What is Biogaia AB's Operating Income?
Operating Income
441.3m SEK

Based on the financial report for Dec 31, 2023, Biogaia AB's Operating Income amounts to 441.3m SEK.

What is Biogaia AB's Operating Income growth rate?
Operating Income CAGR 5Y
10%

Over the last year, the Operating Income growth was 32%. The average annual Operating Income growth rates for Biogaia AB have been 25% over the past three years , 10% over the past five years .

Back to Top